RGDXQ

 
Common Stock SEC Reporting - Delinquent
OTC Pink No Information
Contact Info
  • 1640 Marengo St.
  • 7th Floor
  • Los Angeles, CA 90033

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2015 10-Q
CIK 0001124608
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 3826 - Analytical instruments
Incorporated In: DE, USA
Year of Inc. 1992
Employees 55 a/o Aug 01, 2015
Company Officers/Contacts
Thomas Bolonga CEO
Kevin R. Harris CFO, Principal Fin. Officer
Company Directors
Thomas Bolonga
Richard van den Broek
Kirk K. Calhoun
Sam Chawla
Kevin R. Harris
David Schreiber
Michael Serruya
David M Wurzer
Company Notes
  • Note = On August 9, 2015, the Company filed voluntary chapter 11 bankruptcy petitions with the United States Bankruptcy Court for the District of Delaware in Wilmington, Delaware. The proceeding has been assigned case no.15-11663.
Service Providers
Accounting/Auditing Firm
BDO USA, LLP
1888 Century Park East
4th Floor
Los Angeles, CA, 90067
United States

Legal Counsel
Wilkie Farr & Gallagher
787 Seventh Ave.
New York, NY, 10019
United States

Investor Relations Firm
The Trout Group
740 Broadway
9th Floor
New York, NY, 10003
United States

RGDXQ Security Details
Share Structure
Market Value1 $42,675 a/o Dec 02, 2016
Authorized Shares 70,000,000 a/o Jun 15, 2015
Outstanding Shares 38,795,396 a/o Jun 15, 2015
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 27,341,645 a/o Jun 16, 2015
Par Value No Par Value
Shareholders
Shareholders of Record 1,800 a/o Jun 15, 2015
Short Selling Data
Short Interest 29,403 (30.81%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security